Chronic airway infections in cystic fibrosis (CF) patients provide a setting in which pathogen adaptation can be tracked over years. Identifying the evolutionary paths that allow microbes to colonize and persist could help anticipate clinical outcomes and guide treatment. The adaptive trajectories of Burkholderia multivorans, a leading species within the Burkholderia cepacia complex common in CF airways, are not well characterized. This study aimed to map within-host evolutionary dynamics of B. multivorans and to relate those dynamics to patient lung function.
The analysis followed seven different strains of B. multivorans recovered from chronic airway infections across eight CF patients. Isolates were collected longitudinally over extended periods spanning 7 to 17 years. The manuscript reports comparative genomic and phylodynamic analyses of these patient-specific infecting populations.
Across infections of distinct origin, the populations displayed a consistent phylogenetic trajectory. Each infecting population underwent an initial phase of genetic diversification. Over time, this early diversity was followed by the rise of a single dominant clade or lineage within the patient. The authors emphasize that this pattern—early diversification then dominance—is a reproducible feature across the sampled chronic infections.
Although the infecting strains diverged in origin, the defining mutations characterizing the emergent dominant lineages affected a common set of global regulators in parallel across patients. These repeated targets indicate convergent genetic evolution, where independent bacterial populations acquire mutations in the same genes or pathways during chronic adaptation. The source reports that these mutated genes govern processes relevant to persistence in the CF airway.
The mutations identified in dominant lineages are reported to alter clinically relevant bacterial phenotypes in consistent directions. Specifically, mutated genes were associated with changes in:
The authors note that these adaptive targets unite observations from studies of chronic infections by different species within the Burkholderia cepacia complex.
A central finding reported is that the phylodynamic signal indicating the emergence of a dominant lineage within a patient’s infection correlated with a more rapid decline in lung function. Importantly, this association appears stronger than links to any particular single mutation or set of mutations. In other words, the population-level evolutionary event of a dominant clade taking over the infection was more predictive of accelerated clinical deterioration than were specific genetic changes.
The study highlights the potential clinical value of longitudinal pathogen genomics combined with host outcome data. Detecting the phylodynamic shift toward a dominant lineage could serve as a marker of worsening disease trajectory in CF patients infected with B. multivorans. By revealing shared adaptive pathways—global regulators affecting lipid metabolism, immune interactions, antibiotic tolerance, biofilm biology, and hypoxia survival—the work may point to conserved bacterial vulnerabilities that could be targeted to limit persistence and progression.
This manuscript is a preprint and has not been peer reviewed; the authors explicitly state that the work awaits formal peer evaluation. The abstract summarizes key results, but additional methodological specifics, cohort-level data, statistical analyses, and full experimental details are contained in the source text and supporting materials. Where those specifics are not detailed in the abstract, they are not reported here.
Overall, the reported findings support a model in which independently evolving B. multivorans populations converge on similar regulatory targets during chronic CF airway infection, and where the emergence of a dominant lineage within an infection is associated with faster lung function decline. The authors argue for integrating pathogen and host data to better link bacterial adaptation to clinical outcomes and to identify opportunities to reinforce host defenses.